For McDonald's, a Minor Menu Change Requires Extensive Planning

Related Link: 

McDonald’s has been planning extensively for its shift to chicken made from birds raised without antibiotics that are important to human health.

Watchdog's Hunt Is Short on 'Wolves' of Wall Street

Related Link: 

Finra’s “High Risk Broker” program targets individuals with large numbers of disciplinary red flags, but the initiative hasn’t barred any of the brokers associated with Stratton Oakmont, the firm depicted in the film ‘The Wolf of Wall Street.’

Canadian Natural Resources Profit Rises

Related Link: 

Canadian Natural Resources, one of Canada’s largest oil sands and natural gas producers, raised its dividend and reported a nearly threefold increase in fourth-quarter profits Thursday as stronger production helped offset slumping crude-oil prices.

Handbag Prices Begin to Hit Their Limit

Related Link: 

For years, prices of high-end handbags rose sharply, but now even wealthy buyers are pushing back. As a result, design houses including Gucci, Fendi, Prada and Mulberry are adding lower-price items.

Costco Profits Surge on Lower Fuel Costs

Related Link: 

Costco Wholesale reported a better-than-expected 29% rise in earnings in the February quarter, boosted by a tax benefit and lower fuel prices.

Mallinckrodt to Buy Critical Care Company

Related Link: 

Mallinckrodt agreed to buy privately held Ikaria for about $2.3 billion, in a move to expand its presence in hospitals and in the area of critical care.

Emirates Boss Rebuts Unfair Aid Claims

Related Link: 

Emirates Airline President Tim Clark plans face-to-face meetings with U.S. government officials later this month to try to counter claims by the Persian Gulf carrier’s U.S. rivals that it benefits from unfair state aid and should be constrained.

Telecom-maker Ciena Reports Wider Loss

Related Link: 

Telecom-equipment maker Ciena Corp. posted a wider loss and disappointing revenue in its January quarter, weighed by foreign exchange and the timing of orders.

AbbVie in $21 Billion Biotech Deal

Related Link: 

AbbVie said it will buy cancer biotech Pharmacyclics in a $21 billion deal that returns the Chicago drug company to deal-making after backing away from a big tax-lowering takeover last year.

Xstrata Ex-CEO Raises $5.6 Billion for Mining Deals

Related Link: 

Former Xstrata chief Mick Davis has raised $5.6 billion for his fund, X2 Resources, and plans to start deploying cash in the next few months, according to people familiar with the fund’s plans.

Syndicate content